SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Mauger Pierre

(Last)

(First)

(Middle)

C/O BUNGE LTD.

50 MAIN STREET, 6TH FLOOR

(Street)

WHITE PLAINS

10606

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/08/2019

3. Issuer Name and Ticker or Trading Symbol
Bunge LTD [ BG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Transformation Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	17,752⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to buy)	⁽²⁾	03/31/2023	Common Stock	12,000	$73.65	D
Stock Options (Right to buy)	⁽³⁾	02/27/2024	Common Stock	18,750	$79.47	D
Stock Options (Right to buy)	⁽⁴⁾	02/26/2025	Common Stock	20,850	$81.68	D
Stock Options (Right to buy)	⁽⁵⁾	03/01/2026	Common Stock	44,500	$50.07	D
Stock Options (Right to buy)	⁽⁶⁾	03/08/2027	Common Stock	34,000	$81	D
Stock Options (Right to buy)	⁽⁷⁾	02/28/2028	Common Stock	31,000	$75.99	D
Stock Options (Right to buy)	⁽⁸⁾	03/12/2029	Common Stock	27,500	$51.89	D

Explanation of Responses:

1. Includes (i) 2,800 restricted stock units ("RSUs") that were granted to the insider on March 8, 2017 and 158 RSUs acquired pursuant to a dividend reinvestment feature that will vest on March 8, 2020 and (ii) 8,000 RSUs that were granted to the insider on March 12, 2019 that will vest on March 12, 2022. One RSU is convertible into one share of Bunge Ltd. common stock

2. This option became exercisable in three equal installments beginning April 1, 2014.

3. This option became exercisable in three equal annual installments beginning on February 28, 2015.

4. This option became exercisable in three equal annual installments beginning on February 27, 2016.

5. This option became exercisable in three equal annual installments beginning on March 1, 2017.

6. This option became exercisable in three equal annual installments beginning on March 8, 2018.

7. This option became exercisable in three equal annual installments beginning on February 28, 2019.

8. This option is exercisable in three equal annual insstallments beginning on March 12, 2020.

Remarks:

	/s/ John Tropeano, Attorney-in-Fact	05/20/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.